- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 12 residues within 4Å:- Chain A: K.55, E.59, G.133, R.134, N.135, G.136, Y.137, G.138, K.350
- Ligands: ADP.1, ITH.7, ITH.14
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:E.59, A:N.135, A:N.135, A:G.136, A:Y.137, A:G.138
- Salt bridges: A:K.55, A:K.350
SO4.3: 6 residues within 4Å:- Chain A: A.219, R.223, G.224, V.225, N.237, G.238
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:G.224, A:V.225, A:N.237, A:G.238
- Salt bridges: A:R.223
SO4.4: 2 residues within 4Å:- Chain A: D.204, K.205
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.205
SO4.5: 3 residues within 4Å:- Chain A: K.159, H.160, H.180
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:H.160, A:H.180
SO4.9: 12 residues within 4Å:- Chain B: K.55, E.59, G.133, R.134, N.135, G.136, Y.137, G.138, K.350
- Ligands: ITH.7, ADP.8, ITH.14
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:E.59, B:N.135, B:N.135, B:G.136, B:Y.137, B:G.138
- Salt bridges: B:K.55, B:K.350
SO4.10: 6 residues within 4Å:- Chain B: A.219, R.223, G.224, V.225, N.237, G.238
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:G.224, B:V.225, B:N.237, B:G.238
- Salt bridges: B:R.223
SO4.11: 2 residues within 4Å:- Chain B: D.204, K.205
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.205
SO4.12: 3 residues within 4Å:- Chain B: K.159, H.160, H.180
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:H.160, B:H.180
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ITH: 4-[(2S,3R)-3-[3,5-bis(oxidanylidene)piperazin-1-ium-1-yl]butan-2-yl]piperazin-4-ium-2,6-dione(Non-covalent)
ITH.7: 18 residues within 4Å:- Chain A: H.14, T.21, Y.22, N.135, Y.137, L.141, Q.348
- Chain B: H.14, T.21, Y.22, K.55, N.135, Y.137, L.141, Q.348
- Ligands: SO4.2, SO4.9, ITH.14
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:Y.22, B:Q.348
- Hydrogen bonds: B:T.21, B:K.55, B:N.135
- pi-Cation interactions: A:Y.137
ITH.14: 18 residues within 4Å:- Chain A: H.14, T.21, Y.22, K.55, N.135, Y.137, L.141, Q.348
- Chain B: H.14, T.21, Y.22, N.135, Y.137, L.141, Q.348
- Ligands: SO4.2, ITH.7, SO4.9
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Y.22, A:Q.348
- Hydrogen bonds: A:K.55, A:N.135, B:T.21
- pi-Cation interactions: B:Y.137
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ling, E.M. et al., A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193. Structure (2022)
- Release Date
- 2022-05-25
- Peptides
- DNA topoisomerase 2-beta: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ITH: 4-[(2S,3R)-3-[3,5-bis(oxidanylidene)piperazin-1-ium-1-yl]butan-2-yl]piperazin-4-ium-2,6-dione(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ling, E.M. et al., A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193. Structure (2022)
- Release Date
- 2022-05-25
- Peptides
- DNA topoisomerase 2-beta: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A